Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
PFIZER LIMITED ( (IN:PFIZER) ) has issued an announcement.
The stock exchange has requested clarification from Pfizer Limited regarding its financial results for the quarter ended 30 September 2025, specifically in relation to compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company’s response is still awaited, leaving investors and other stakeholders without further detail on the nature of the exchange’s queries or any potential implications for Pfizer Limited’s financial reporting and regulatory compliance until the clarification is provided.
More about PFIZER LIMITED
Pfizer Limited is a pharmaceutical company engaged in the development, manufacture and marketing of prescription medicines and healthcare products, operating within the broader healthcare and life sciences industry.
Average Trading Volume: 4,284
Technical Sentiment Signal: Hold
Current Market Cap: 222.7B INR
See more insights into PFIZER stock on TipRanks’ Stock Analysis page.